Inflammasomes: Molecular regulation and implications for metabolic and cognitive diseases

Molecules and Cells

Volumn 37, Issue 6, 2014, Pages 441-448

  Choi, Alexander J S ^a   Ryter, Stefan W ^b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cognitive disease; Diabetes; Inflammasome; Inflammation; Metabolism; Obesity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MULTIPROTEIN COMPLEX; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR; CARRIER PROTEIN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN;

ALZHEIMER DISEASE; COGNITIVE DEFECT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; INSULIN RESISTANCE; MAJOR DEPRESSION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARKINSON DISEASE; PATHOGENESIS; POTASSIUM TRANSPORT; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; IMMUNOLOGY; MENTAL DISEASE; METABOLISM;

CARRIER PROTEINS; HUMANS; INFLAMMASOMES; MENTAL DISORDERS; METABOLIC DISEASES; SIGNAL TRANSDUCTION;

EID: 84903897249     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0104     Document Type: Short Survey

References (86)

1. Alcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J.A., Fernández- Rodríguez, A., and Cordero, M.D. (2013). NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav. Immun. 36, 111-117.
2. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., Guthrie E.H., Pickles, R.J., and Ting, J.P. (2009). The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556-565.
3. Balistreri, C.R., Colonna-Romano, G., Lio, D., Candore, G., and Caruso, C. (2009). TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol. 29, 406-415.
4. Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., et al. (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787-791.
5. Chatterjee, S., Rana, R., Corbett, J., Kadiiska, M.B., Goldstein, J., and Mason, R.P. (2012). P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice. Free Radic. Biol. Med. 52, 1666-1679.
6. Davis, B.K., Wen, H., and Ting, J.P. (2011). The Inflammasome NLRs in immunity, inflammation, and associated diseases. Ann. Rev. Immun 29, 707-735.
7. Devi, T.S., Lee, I., Hüttemann, M., Kumar, A., Nantwi, K.D., and Singh, L.P. (2012). TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp. Diabetes Res. 2012, 438238.
8. Donath, M.Y., and Shoelson, S.E. (2011). Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.
9. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., and Tschopp J. (2008). Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677. (Pubitemid 351928351)
10. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., and Lanctôt, K.L. (2010). A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457.
11. Eizirik, D.L., Sammeth, M, Bouckenooghe, T., Bottu, G., Sisino, G., Igoillo-Esteve, M., Ortis, F., Santin, I., Colli, M.L., Barthson, J., et al. (2012). The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of proinflammatory cytokines. PLoS Genet. 8, e1002552.
12. Emanuela, F., Grazia, M., Marco de, R., Maria Paola, L., Giorgio, F., and Marco, B. (2012). Inflammation as a link between obesity and metabolic syndrome. J. Nutr. Metab. 2012, 476380.
13. Faustin, B., Lartigue, L., Bruey, J.M., Luciano, F., Sergienko, E., Bailly-Maitre, B., Volkmann, N., Hanein, D., Rouiller, I., and Reed, J.C. (2007). Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724. (Pubitemid 46341921)
14. Feve, B., and Bastard, J.P. (2009). The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 5, 305-311
15. Finucane, M.M., Stevens, G.A., Cowan, M.J., Danaei, G., Lin, J.K., Paciorek, C.J., Singh, G.M., Gutierrez, H.R., Lu, Y., Bahalim, A.N., et al. (2011). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 337, 557-567.
16. Franchi, L., Eigenbrod, T., and Nuñez, G. (2009). Cutting edge: TNF-a mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 183, 792-796.
17. Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., and Ikeda, H. (2003). Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100, 171-194. (Pubitemid 37377912)
18. Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C., and Gage, F.H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934.
19. Glinsky, G.V. (2008). SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways. Cell Cycle 7, 3564-3576.
20. Guarda, G., Zenger, M., Yazdi, A.S., Schroder, K., Ferrero, I., Menu, P., Tardivel, A., Mattmann, C., and Tschopp, J. (2011). Differential expression of NLRP3 among hematopoietic cells. J. Immunol. 186, 2529-2534.
21. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., and Golenbock, D.T. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857-865.
22. Heid, M.E., Keyel, P.A., Kamga, C., Shiva, S., Watkins, S.C., and Salter, R.D. (2013). Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J. Immunol. 191, 5230-5238.
23. Heneka, M.T., Kummer, M.P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, TC., et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678.
24. Hentze, H., Lin, X.Y., Choi, M.S., and Porter, A.G. (2003). Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ. 10, 956-968. (Pubitemid 37069473)
25. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G., et al. (1993). Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13, 6231-6240. (Pubitemid 23292617)
26. Hook, V.Y., Kindy, M., and Hook, G. (2008). Inhibitors of cathepsin B Improve memory and reduce b-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, b-secretase site of the amyloid precursor protein. J. Biol. Chem. 283, 7745-7753.
27. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and Latz, E. (2008). Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856.
28. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E., and Fitzgerald, K.A. (2009). AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
29. Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S., and Selkoe, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182. (Pubitemid 19271472)
30. Iwata, M., Ota, K.T., and Duman, R.S. (2013). The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav. Immun. 31, 105-114.
31. Jankowsky, J.L., Slunt, H.H., Ratovitski, T., Jenkins, N.A., Copeland, N.G., and Borchelt, D.R. (2001). Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 17, 157-165. (Pubitemid 32409891)
32. Kahn, S.E., Hull, R.L., and Utzschneider, K.M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846. (Pubitemid 46024990)
33. Kanneganti, T.D., Lamkanfi, M., Kim, Y.G., Chen, G., Park, J.H., Franchi, L., Vandenabeele, P., and Núñez, G. (2007). Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26, 433-443. (Pubitemid 46603000)
34. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., and National Comorbidity Survey Replication (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 289, 3095-3105. (Pubitemid 37432885)
35. Koo, J.W., and Duman, R.S. (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. USA 105, 751-756.
36. Korcok, J., Raimundo, L.N., Ke, H.Z., Sims, S.M., and Dixon, S.J. (2004). Extracellular nucleotides act through P2X7 receptors to activate NF-kB in osteoclasts. J. Bone Miner. Res. 19, 642-651. (Pubitemid 41071225)
37. Kotas, M.E., Jurczak, M.J., Annicelli, C., Gillum, M.P., Cline, G.W., Shulman, G.I., and Medzhitov, R. (2013). Role of caspase-1 in regulation of triglyceride metabolism. Proc. Natl. Acad. Sci. USA 110, 4810-4815.
38. Lamkanfi, M., Mueller, J.L., Vitari, A.C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W.P., Hoffman, H.M., and Dixit, V.M. (2009). Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187, 61-70.
39. Latz, E., Xiao, T.S., and Stutz, A. (2013). Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397-411.
40. Leemans, J.C., Cassel, S.L., and Sutterwala, F.S. (2011). Sensing damage by the NLRP3 inflammasome. Immunol. Rev. 243, 152-162.
41. Liu, Y., Xiao, Y., and Li, Z. (2011). P2X7 receptor positively regulates MyD88-dependent NF-kB activation. Cytokine 55, 229-236.
42. Lu, M., Sun, X.L., Qiao, C., Liu, Y., Ding, J.H., and Hu, G. (2014). Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation. Neurobiol. Aging 35, 421-430.
43. Ludlow, L.E., Johnstone, R.W., and Clarke, C.J. (2005). The HIN-200 family: more than interferon-inducible genes? Exp. Cell Res. 308, 1-17. (Pubitemid 40984758)
44. Maes, M., Bosmans, E., Meltzer, H.Y., Scharpé, S., and Suy, E. (1993). Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am. J. Psychiatry 150, 1189-1193. (Pubitemid 23218899)
45. Mandrup-Poulsen, T., Pickersgill, L., and Donath, M.Y. (2010). Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 6, 158-166.
46. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., and Dixit, V.M. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218. (Pubitemid 38902430)
47. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol. Cell 10, 417-426. (Pubitemid 35007355)
48. Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241. (Pubitemid 43372104)
49. Martinon, F., Mayor, A., and Tschopp, J. (2009). The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265.
50. Masters, S.L., Dunne, A., Subramanian, S.L., Hull, R.L., Tannahill, G.M., Sharp, F.A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010). Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat. Immunol. 11, 897-904.
51. McGeer, P.L., Itagaki, S., Tago, H., and McGeer, E.G. (1987). Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLADR. Neurosci. Lett. 79, 195-200. (Pubitemid 17144469)
52. Menu, P., and Vince, J.E. (2011). The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin. Exp. Immunol. 166, 1-15.
53. Meyer-Luehmann, M., Spires-Jones, T.L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D.M., Bacskai, B.J., and Hyman, B.T. (2008). Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451, 720-724. (Pubitemid 351220570)
54. Mraz, M., Lacinova, Z., Drapalova, J., Haluzikova, D., Horinek, A., Matoulek, M., Trachta, P., Kavalkova, P., Svacina, S., and Haluzik, M. (2011). The effect of verylow- calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 96, E606-613.
55. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230.
56. Parvathenani, L.K., Tertyshnikova, S., Greco, C.R., Roberts, S.B., Robertson, B., and Posmantur, R. (2003). P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278, 13309-13317. (Pubitemid 36800102)
57. Pelegrin, P., and Surprenant, A. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082. (Pubitemid 44658525)
58. Pelegrin, P., and Surprenant, A. (2007). Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptakeindependent pathway. J. Biol. Chem. 282, 2386-2394. (Pubitemid 47076789)
59. Pétrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F., and Tschopp, J. (2007). Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583-1689.
60. Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., and Alnemri, E.S. (2001). Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276, 28309-28313.
61. Qu, Y., Misaghi, S., Newton, K., Gilmour, L.L., Louie, S., Cupp, J.E., Dubyak, G.R., Hackos, D., and Dixit, V.M. (2006). Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561.
62. Qu, Y., Misaghi, S., Newton, K., Gilmour, L.L., Louie, S., Cupp, J.E., Dubyak, G.R., Hackos, D., and Dixit, V.M. (2011). Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J. Immunol. 186, 6553-6561.
63. Raison, C.L., and Miller, A.H. (2013). Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias. Brain Behav. Immun. 13, 467-475.
64. Saijo, K., Winner, B., Carson, C.T., Collier, J.G., Boyer, L., Rosenfeld, M.G., Gage, F.H., and Glass, C.K. (2009). A Nurr1/CoR EST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59.
65. Sautin, Y.Y., Nakagawa, T., Zharikov, S., and Johnson, R.J. (2007). Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am. J. Physiol. Cell Physiol. 293, C584-C596 (Pubitemid 47235197)
66. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832.
67. Schroder, K., Zhou, R., and Tschopp, J. (2010). The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296-300.
68. Scott, P., Ma, H., Viriyakosol, S., Terkeltaub, R., and Liu-Bryan, R. (2006). Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J. Immunol. 177, 6370-6378. (Pubitemid 44642121)
69. Shoelson, S.E., Lee, J., and Goldfine, A.B. (2006). Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801. (Pubitemid 44033299)
70. Skeldon, A.M., Faraj, M., and Saleh, M. (2014). Caspases and inflammasomes in metabolic inflammation. Immunol. Cell Biol. 92, 304-313.
71. Solini, A., Menini, S., Rossi, C., Ricci, C., Santini, E., Blasetti Fantauzzi, C., Iacobini, C., and Pugliese, G. (2013). The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation. J. Pathol. 231, 342-353.
72. Stienestra, R., Joosten, L.A., Koenen, T., van Tits, B., van Diepen, J.A., van den Berg, S.A., Rensen, P.C., Voshol, P.J., Fantuzzi, G., Hijmans, A., et al. (2010). The inflammasome-mediated caspa-se- 1 activation controls adipocyte differentiation and insulin sensitivity. Metabolism 12, 593-605.
73. Stienestra, R., van Diepen, J.A., Tack, C.J., Zaki, M.H., van de Veerdonk, F.L., Perera, D., Neale, G.A., Hooiveld, G.J., Hijmans, A., Vroegrijk, I., et al. (2011). Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108, 15324-15329.
74. Sun, S., Xia, S., Ji, Y., Kersten, S., and Qi, L. (2012). The ATP-P2 x 7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61, 1471-1478.
75. Trnka, J., Blaikie, F.H., Logan, A., Smith, R.A., and Murphy, M.P. (2009). Antioxidant properties of MitoTEMPOL and its hydroxylamine. Free Radic Res. 43, 4-12.
76. Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M., and Dixit, V.D. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188.
77. van Diepen, J.A., Stienstra, R., Vroegrijk, I.O., van den Berg, S.A., Salvatori, D., Hooiveld, G.J., Kersten, S., Tack, C.J., Netea, M.G., Smit, J.W., et al. (2013). Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion. J. Lipid Res. 54, 448-456.
78. Wang, H., Capell, W., Yoon, J.H., Faubel, S., and Eckel, R.H. (2014a). Obesity development in caspase-1-deficient mice. Int. J. Obes. (Lond) 38, 152-155.
79. Wang, L., Zhai, Y.Q., Xu, L.L., Qiao, C., Sun, X.L., Ding, J.H., Lu, M., and Hu, G. (2014b). Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice. Exp. Neurol. 251, 22-29.
80. Warner-Schmidt, J.L., Vanover, K.E., Chen, E.Y., Marshall, J.J., and Greengard, P. (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc. Natl. Acad. Sci. USA 108, 9262-9267.
81. Wellen, K.E., and Hotamisligil, G.S. (2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119. (Pubitemid 40629025)
82. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T., Brickey, W.J., and Ting, J.P. (2011). Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408-415.
83. World Health Organization. (2002). The world health report 2002: Reducing risks, promoting healthy life. Geneva WHO 1-167.
84. World Health Organization. (2011). Global status report on noncommunicable diseases 2010. Geneva WHO 1-162.
85. Zhang, Y., Liu, L., Peng, Y.L., Liu, Y.Z., Wu, T.Y., Shen, X.L., Zhou, J.R., Sun, D.Y., Huang, A.J., Wang, X., et al. (2013). Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci. Ther. 20, 119-124.
86. Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. (2010). Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140.